Skip to content
10-K

Annual Report

Bioventus Inc. BVS

0001665988-26-000011

← back to feed
Filed
Mar 5, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 68.91M sh
Shares Diluted FY 2025 · Dec 31, 2024 64.55M sh
Shares Diluted FY 2025 · Dec 31, 2023 62.65M sh
Capex FY 2025 · Dec 31, 2025 $2.56M
Capex FY 2025 · Dec 31, 2024 $1.01M
Capex FY 2025 · Dec 31, 2023 $7.36M
Operating Cash Flow FY 2025 · Dec 31, 2025 $74.67M
Operating Cash Flow FY 2025 · Dec 31, 2024 $38.8M
Operating Cash Flow FY 2025 · Dec 31, 2023 $15.34M
Long Term Debt FY 2025 · Dec 31, 2025 $278.95M
Long Term Debt FY 2025 · Dec 31, 2024 $308.29M
Short Term Debt FY 2025 · Dec 31, 2025 $15M
Short Term Debt FY 2025 · Dec 31, 2024 $27.34M
Cash And Equivalents FY 2025 · Dec 31, 2025 $51.24M
Cash And Equivalents FY 2025 · Dec 31, 2024 $41.58M
Stockholders Equity FY 2025 · Dec 31, 2025 $184.11M
Stockholders Equity FY 2025 · Dec 31, 2024 $147.94M
Current Liabilities FY 2025 · Dec 31, 2025 $160.38M
Current Liabilities FY 2025 · Dec 31, 2024 $210.4M
Total Liabilities FY 2025 · Dec 31, 2025 $455.11M
Total Liabilities FY 2025 · Dec 31, 2024 $542.35M
Current Assets FY 2025 · Dec 31, 2025 $272.84M
Current Assets FY 2025 · Dec 31, 2024 $275.61M
Total Assets FY 2025 · Dec 31, 2025 $683.56M
Total Assets FY 2025 · Dec 31, 2024 $727.96M
Eps Diluted FY 2025 · Dec 31, 2025 $0.33
Eps Diluted restated FY 2025 · Dec 31, 2024 −$0.56
Eps Diluted FY 2025 · Dec 31, 2023 −$2.49
Eps Basic FY 2025 · Dec 31, 2025 $0.34
Eps Basic restated FY 2025 · Dec 31, 2024 −$0.56
Eps Basic FY 2025 · Dec 31, 2023 −$2.49
Sga Expense FY 2025 · Dec 31, 2025 $314.03M
Sga Expense restated FY 2025 · Dec 31, 2024 $343.8M
Sga Expense FY 2025 · Dec 31, 2023 $303.88M
Rd Expense FY 2025 · Dec 31, 2025 $12.11M
Rd Expense restated FY 2025 · Dec 31, 2024 $13.95M
Rd Expense FY 2025 · Dec 31, 2023 $13.45M
Net Income FY 2025 · Dec 31, 2025 $22.73M
Net Income restated FY 2025 · Dec 31, 2024 −$36.13M
Net Income FY 2025 · Dec 31, 2023 −$156.23M
Operating Income FY 2025 · Dec 31, 2025 $53.98M
Operating Income restated FY 2025 · Dec 31, 2024 −$15.2M
Operating Income FY 2025 · Dec 31, 2023 −$81.73M
Gross Profit FY 2025 · Dec 31, 2025 $388.16M
Gross Profit FY 2025 · Dec 31, 2024 $388.23M
Gross Profit FY 2025 · Dec 31, 2023 $328.19M
Cost Of Revenue FY 2025 · Dec 31, 2025 $179.93M
Cost Of Revenue FY 2025 · Dec 31, 2024 $185.05M
Cost Of Revenue FY 2025 · Dec 31, 2023 $184.15M
Revenue FY 2025 · Dec 31, 2025 $568.09M
Revenue FY 2025 · Dec 31, 2024 $573.28M
Revenue FY 2025 · Dec 31, 2023 $512.35M